AB
GOSS icon

Amalgamated Bank’s Gossamer Bio GOSS Stock Holding History

Amalgamated Bank’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75
Closed -$19K – 2125
2025
Q4 		$19K Sell
75
-6
-7% -$1.37K ﹤0.01% 2125
2025
Q3 		$17K Hold
81
– – ﹤0.01% 2197
2025
Q2 		$8K Buy
+81
New +$7.07K ﹤0.01% 2525
2023
Q2 		– Sell
-109
Closed -$11K – 3065
2023
Q1 		$11K Sell
109
-17
-13% -$2.6K ﹤0.01% 2792
2022
Q4 		$22K Hold
126
– – ﹤0.01% 2724
2022
Q3 		$120K Buy
126
+2
+2% +$1.99K ﹤0.01% 2068
2022
Q2 		$83K Buy
124
+30
+32% +$18.6K ﹤0.01% 2249
2022
Q1 		$65K Buy
+94
New +$72.5K ﹤0.01% 2346

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Amalgamated Bank's GOSS Position: Q1 2026 in Review

Amalgamated Bank sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 75 shares — an estimated $19K sold.

Amalgamated Bank first reported a position in GOSS in Q1 2022 and held it in 8 quarters. The position peaked at $120K in Q3 2022. 181 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Amalgamated Bank reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 75 Gossamer Bio shares in Q1 2026, an estimated $19K.
  • Amalgamated Bank first reported a position in Gossamer Bio in Q1 2022 and held it in 8 quarters.
  • Amalgamated Bank's Gossamer Bio position peaked at $120K in Q3 2022.
  • 181 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.